A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand

Vincenzo de Sanctis; Duran Canatan; Joan Lluis Vives Corrons; Mehran Karimi; Shahina Daar; Christos Kattamis; Ashraf T. Soliman; Yasser Wali; Salam Alkindi; Valeh Huseynov; Afag Nasibova; Tarık Onur Tiryaki; Melike Sezgin Evim; Adalet Meral Gunes; Zeynep Karakas; Soteroula Christou; Mohamed A. Yassin; Maria Concetta Galati; Saveria Campisi; Tahereh Zarei; Doaa Khater; Yesim Oymak; Valeriya Kaleva; Denka Stoyanova; Atanas Banchev; Myrto Skafida; Yurdanur Kilinc

doi:10.23750/abm.v91i3.10063

A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand

Vincenzo de Sanctis^*, Duran Canatan, Joan Lluis Vives Corrons, Mehran Karimi, Shahina Daar, Christos Kattamis, Ashraf T. Soliman, Yasser Wali, Salam Alkindi, Valeh Huseynov, Afag Nasibova, Tarık Onur Tiryaki, Melike Sezgin Evim, Adalet Meral Gunes, Zeynep Karakas, Soteroula Christou, Mohamed A. Yassin, Maria Concetta Galati, Saveria Campisi, Tahereh ZareiDoaa Khater, Yesim Oymak, Valeriya Kaleva, Denka Stoyanova, Atanas Banchev, Myrto Skafida, Yurdanur Kilinc

^*Corresponding author for this work

Haematology

Research output: Contribution to journal › Review article › peer-review

7 Citations (Scopus)

Abstract

A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID-19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations. (www.actabiomedica.it).

Original language	English
Article number	e2020026
Pages (from-to)	1-7
Number of pages	7
Journal	Acta Biomedica
Volume	91
Issue number	3
DOIs	https://doi.org/10.23750/abm.v91i3.10063
Publication status	Published - Sept 11 2020

Keywords

Associated co-morbidities
COVID-19 pandemic
Clinical outcome
Iron overload
Thalassemias
Update

ASJC Scopus subject areas

General Medicine

Access to Document

10.23750/abm.v91i3.10063

Cite this

de Sanctis, V., Canatan, D., Corrons, J. L. V., Karimi, M., Daar, S., Kattamis, C., Soliman, A. T., Wali, Y., Alkindi, S., Huseynov, V., Nasibova, A., Tiryaki, T. O., Evim, M. S., Gunes, A. M., Karakas, Z., Christou, S., Yassin, M. A., Galati, M. C., Campisi, S., ... Kilinc, Y. (2020). A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand. Acta Biomedica, 91(3), 1-7. Article e2020026. https://doi.org/10.23750/abm.v91i3.10063

de Sanctis, V, Canatan, D, Corrons, JLV, Karimi, M, Daar, S, Kattamis, C, Soliman, AT, Wali, Y, Alkindi, S, Huseynov, V, Nasibova, A, Tiryaki, TO, Evim, MS, Gunes, AM, Karakas, Z, Christou, S, Yassin, MA, Galati, MC, Campisi, S, Zarei, T, Khater, D, Oymak, Y, Kaleva, V, Stoyanova, D, Banchev, A, Skafida, M & Kilinc, Y 2020, 'A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand', Acta Biomedica, vol. 91, no. 3, e2020026, pp. 1-7. https://doi.org/10.23750/abm.v91i3.10063

@article{7e7e19717727402b8abe4342ff097ff4,

title = "A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand",

abstract = "A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID-19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations. (www.actabiomedica.it).",

keywords = "Associated co-morbidities, COVID-19 pandemic, Clinical outcome, Iron overload, Thalassemias, Update",

author = "{de Sanctis}, Vincenzo and Duran Canatan and Corrons, {Joan Lluis Vives} and Mehran Karimi and Shahina Daar and Christos Kattamis and Soliman, {Ashraf T.} and Yasser Wali and Salam Alkindi and Valeh Huseynov and Afag Nasibova and Tiryaki, {Tarık Onur} and Evim, {Melike Sezgin} and Gunes, {Adalet Meral} and Zeynep Karakas and Soteroula Christou and Yassin, {Mohamed A.} and Galati, {Maria Concetta} and Saveria Campisi and Tahereh Zarei and Doaa Khater and Yesim Oymak and Valeriya Kaleva and Denka Stoyanova and Atanas Banchev and Myrto Skafida and Yurdanur Kilinc",

year = "2020",

month = sep,

day = "11",

doi = "10.23750/abm.v91i3.10063",

language = "English",

volume = "91",

pages = "1--7",

journal = "Acta Biomedica",

issn = "0392-4203",

publisher = "L'Ateneo Parmense",

number = "3",

}

TY - JOUR

T1 - A comprehensive update of ICET-a network on COVID-19 in thalassemias

T2 - What we know and where we stand

AU - de Sanctis, Vincenzo

AU - Canatan, Duran

AU - Corrons, Joan Lluis Vives

AU - Karimi, Mehran

AU - Daar, Shahina

AU - Kattamis, Christos

AU - Soliman, Ashraf T.

AU - Wali, Yasser

AU - Alkindi, Salam

AU - Huseynov, Valeh

AU - Nasibova, Afag

AU - Tiryaki, Tarık Onur

AU - Evim, Melike Sezgin

AU - Gunes, Adalet Meral

AU - Karakas, Zeynep

AU - Christou, Soteroula

AU - Yassin, Mohamed A.

AU - Galati, Maria Concetta

AU - Campisi, Saveria

AU - Zarei, Tahereh

AU - Khater, Doaa

AU - Oymak, Yesim

AU - Kaleva, Valeriya

AU - Stoyanova, Denka

AU - Banchev, Atanas

AU - Skafida, Myrto

AU - Kilinc, Yurdanur

PY - 2020/9/11

Y1 - 2020/9/11

N2 - A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID-19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations. (www.actabiomedica.it).

AB - A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID-19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations. (www.actabiomedica.it).

KW - Associated co-morbidities

KW - COVID-19 pandemic

KW - Clinical outcome

KW - Iron overload

KW - Thalassemias

KW - Update

UR - http://www.scopus.com/inward/record.url?scp=85090872741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090872741&partnerID=8YFLogxK

U2 - 10.23750/abm.v91i3.10063

DO - 10.23750/abm.v91i3.10063

M3 - Review article

C2 - 32921722

AN - SCOPUS:85090872741

SN - 0392-4203

VL - 91

SP - 1

EP - 7

JO - Acta Biomedica

JF - Acta Biomedica

IS - 3

M1 - e2020026

ER -

A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this